IL1B and malignant colon neoplasm: Increased CTLA4 levels also correlate with IL-1β expression CC as IL-1β increases the signal transduction of the CTLA4; therefore, targeting the IL-1β–CTLA4 axis may help to overcome the CC immunosuppressive TIME, as seen in colon cancer [118,120].